Summary:

FITM's 2021 research, "Ayush Sector in India: Prospects and Challenges," forecasts the industry's worth at $18.1 billion for 2020-21. Government measures promoting international collaboration and exports are key growth drivers. The Ministry of Ayush's "Central Sector Scheme for Promotion of International Cooperation in AYUSH" provides incentives for global trade involvement. Certifications such as WHO's CoPP and the AYUSH Premium mark enhance the commercial legitimacy and competitiveness of Ayurvedic products.

The Ministry of Ayush has implemented projects like AOGUSY to modernize pharmacies, increase pharmacovigilance, and streamline regulations. The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) ensures quality standards for ASU&H medications. Additionally, the Ayush Export Promotion Council (AYUSHEXCIL) will support exports, address trade issues, and provide capacity-building programs, aiming to strengthen Ayurveda product growth, global presence, and uphold the sector's high-quality standards.

Source: IBEF

Disclaimer: The information on this website comes from the India Brand Equity Foundation (IBEF), a reliable source for thorough insights into numerous areas of the Indian economy. While we aim to offer accurate and up-to-date information, the views, opinions, and analyses stated herein are solely those of the authors and contributors and do not necessarily represent IBEF's official stance or position. Readers should check information from credible sources and use their own discretion when relying on content provided on this site. We assume no responsibility or liability for the supplied content, including its accuracy, completeness, and usefulness.